Janssen Vaccines to start coronavirus trials in Netherlands in September
Topics: JANSSEN VACCINES
Janssen, part of the giant Johnson and Johnson pharmaceuticals group, has already begun trials of the vaccine in Belgium and the U.S., where it is quicker to get permission for human testing. The study currently underway involves giving participants two vaccinations, eight weeks apart.
‘In September we will look at giving less of the vaccine and if the interval can be made shorter,’ research leader Hanneke Schuitemaker told television programme Nieuwsuur on Monday evening.
"The trials will be managed by Utrecht and Leiden teaching hospitals, among others, according to the Financieele Dagblad. Four pharmaceuticals companies are currently in phase three of testing a potential coronavirus vaccine involving major human trials, and Janssen Vaccines hopes to enter phase 3 by October.
‘Nine out of 10 vaccines fail in the final phase of development, so it is not a done deal,’ Schuitemaker said. Phase 3 trials determine if a vaccine offers sufficient protection. The Dutch government is part of a group of EU countries which have preordered three million vaccines from AstraZeneca, which hopes to have its first vaccines ready by the end of this year. ■